Retinal vein occlusion

被引:0
|
作者
Mekjavic, Poona Jaki [1 ]
Mavri, Alenka [2 ]
Stalc, Monika [2 ]
机构
[1] UKC Ljubljana, Ocesna Klin, Ljubljana, Slovenia
[2] UKC Ljubljana, Interna Klin, Klin Oddeleh Zline Bolezni, Ljubljana, Slovenia
来源
ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL | 2011年 / 80卷 / 11期
关键词
retina; vein occlusion; cardiovascular risk factors; trombophilia; MACULAR EDEMA SECONDARY; RISK-FACTORS; INTRAVITREAL BEVACIZUMAB; METAANALYSIS; MANAGEMENT; INTERVENTIONS; HOMOCYSTEINE; PREVALENCE; DALTEPARIN; THROMBOSIS;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Retinal vein occlusion is a common disease, especially in the elderly, and is associated with significant visual morbidity, as a consequence of persistent macular oedema, macular ischemia, and in the advanced stages of the disease, due to retinal or iris neovascularisation with vitreal haemorrhages or neovascular glaucoma. There are two types of retinal vein occlusion with respect to the site of occlusion: branch retinal vein occlusion and central retinal vein occlusion. The obstruction is mainly due to external compression of the rigid artery over a vein. The main risk factors for retinal vein occlusion are established cardiovascular risk factors: hypertension, hyperlipidemia and diabetes mellitus, whereas inherited or acquired types of trombophilia play a minor role. An overview of diagnostic and treatment aproaches, and guidlines for follow-up of patients with retinal vein occlusion are presented.
引用
收藏
页码:805 / 819
页数:15
相关论文
共 50 条
  • [1] Antiphospholipid syndrome and retinal vein occlusion
    Rehak, M.
    Mueller, M.
    Scholz, M.
    Wiercinska, J.
    Niederwieser, D.
    Wiedemann, P.
    OPHTHALMOLOGE, 2009, 106 (05): : 427 - 434
  • [2] Retinal vein occlusion
    Heron, E.
    REVUE DE MEDECINE INTERNE, 2010, 31 (06): : 434 - 439
  • [3] Retinal vein occlusion Therapy of retinal vein occlusion
    Feltgen, N.
    Pielen, A.
    OPHTHALMOLOGE, 2015, 112 (08): : 695 - 704
  • [4] Thrombophilia and vascular risk factors in retinal vein occlusion
    Napa Lecumberri, J. J.
    Sedano Balbas, C.
    Canal Villanueva, J.
    Hernandez Hernandez, J. L.
    REVISTA CLINICA ESPANOLA, 2013, 213 (05): : 229 - 234
  • [5] Comparison of systemic conditions at diagnosis between central retinal vein occlusion and branch retinal vein occlusion
    Cho, Bum-Joo
    Bae, So Hyun
    Park, Sang Min
    Shin, Min Chul
    Park, In Won
    Kim, Ha Kyoung
    Kwon, Soonil
    PLOS ONE, 2019, 14 (08):
  • [6] Thrombophilic and cardiovascular risk factors for retinal vein occlusion
    Bucciarelli, Paolo
    Passamonti, Serena M.
    Gianniello, Francesca
    Artoni, Andrea
    Martinelli, Ida
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2017, 44 : 44 - 48
  • [7] Investigational drugs for retinal vein occlusion
    Bremond-Gignac, Dominique
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2016, 25 (07) : 841 - 850
  • [8] Retinal Vein Occlusion and Angle Closure: A Retrospective Case Series
    Michaelides, Michel
    Foster, Paul J.
    JOURNAL OF GLAUCOMA, 2010, 19 (09) : 643 - 649
  • [9] Nonvalvular atrial fibrillation and retinal vein occlusion: The Valdecilla Cohort
    Bores, P. Gonzalez
    Lecumberri, J. J. Napal
    Hernandez, J. M. de la Torre
    Galan, B. Gonzalez-Mesones
    Hernandez, J. L. Hernandez
    REVISTA CLINICA ESPANOLA, 2023, 223 (02): : 77 - 83
  • [10] Clinical implications of retinal oximetry in retinal vein occlusion: a review
    Belamkar, Aditya, V
    Jabbehdari, Sayena
    Harris, Alon
    Hajrasouliha, Amir R.
    ACTA OPHTHALMOLOGICA, 2022, 100 (06) : 624 - 631